Pure Extracts Technologies Corp. PULL has decided to join the growing mushroom industry via collaboration with The Nutraceutical Medicine Company Inc.
The cannabis and hemp-focused extraction company signed a letter of intent with The Nutraceutical Medicine Company Inc., which owns Purica, a brand of full-spectrum mushroom derived products.
The goal is to co-create CBD-full-spectrum mushroom wellness products.
Purica is praised for its award-winning immunity product, Immune 7, and for educating the population about the betterment medicinal mushroom products can bring in a variety of ailments, from stress and sleep issues, to hormonal imbalance. The company has been operating for more than 20 years.
“We are excited to be working with the experts at PURICA on functional mushroom products and novel CBD formulations,” Pure Extracts CEO, Ben Nikolaevsky, said in a statement. “They have an impressive history of product development, customer retention and an unwavering dedication to high standards.”
Pure Extracts noted that this collaboration could help the company attain a powerful position in both the CBD and mushroom industry, enabling it to make a “ground-breaking achievement.”
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.